At Biognosys, we offer SISCAPA (Stable Isotope Standards and Capture by Anti-Peptide Antibodies) as a cutting-edge targeted proteomics solution for ultra-sensitive and precise quantification of low-abundance proteins in complex biological samples. By combining stable isotope-labeled standards (SIS), enzymatic digestion, and proprietary, stringently selected, high affinity anti-proteotypic peptide antibodies, our workflow enables interference-free quantification of targeted analyses of interest.
Integrated with our high-resolution targeted mass spectrometry platform and advanced data processing, we provide an end-to-end solution that overcomes the limitations of traditional immunoassays. With built-in interference-free absolute quantification and powerful multiplexing capabilities, researchers and pharma partners can confidently quantify challenging proteins with unmatched sensitivity, specificity, and clinical readiness.
To support translational and clinical applications, our platform integrates automated sample preparation and GCP-compliant processes, ensuring clinical-grade robustness, regulatory alignment, and reliable data generation — making SISCAPA ideally suited for bioanalytical and clinical research.
Sample Preparation: SIS peptides and in some cases recombinant protein(s) are spiked into extracted proteins from various biological matrices, including plasma, dried blood spots, cerebrospinal fluid, serum, and tissue lysates.
Enzymatic Digestion: Proteins are digested to generate target peptides, including proteotypic peptides of interest.
Peptide Enrichment: High-affinity, highly specific anti-peptide antibodies capture target peptides, removing background interference.
Targeted Detection: Enriched peptides are analyzed via targeted mass spectrometry, improving signal-to-noise ratios and enabling detection of proteins often undetectable by traditional methods.
Data Output: The combined use of SIS and recombinant protein(s) allows quantitative measurements of target proteins with great accuracy.
SISCAPA Assay Technologies offers ready-to-use and custom assays for precise protein quantification across therapeutic areas including oncology, cardiology, inflammation, infectious disease, and metabolic disorders.


Biognosys is committed to providing the best possible results to our customers at the fastest possible project turnaround time.